or Try an Advanced Search...

    Technical Analysis for ATAI - ATAI Life Sciences N.V.

    Grade Last Price % Change Price Change
    B 1.84 -1.60% -0.03
    ATAI closed down 1.6 percent on Thursday, April 25, 2024, on 47 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 7
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical ATAI trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Centerline Cross Bearish -1.60%
    Stochastic Buy Signal Bullish -1.60%
    Wide Bands Range Expansion -1.60%
    Oversold Stochastic Weakness -1.60%
    50 DMA Resistance Bearish -6.60%
    Bullish Engulfing Bullish -6.60%
    Wide Bands Range Expansion -6.60%
    Oversold Stochastic Weakness -6.60%
    Older End-of-Day Signals for ATAI ...

       Recent Intraday Alerts

    Alert Time
    Up 2% about 19 hours ago
    10 DMA Resistance about 19 hours ago
    Fell Below 200 DMA about 19 hours ago
    Reversed from Down about 20 hours ago
    200 DMA Support about 20 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ATAI Chart by TradingView
    Basic chart:

    Profile

    atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, as well as the emergence of therapies that previously may have been overlooked or underused, including psychedelic compounds and digital therapeutics. atai is headquartered in Berlin, with offices in New York and London.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Medication Disability Mental Health Psychiatry Mental Disorder Positive Psychology Mental Health Disorders

    Is ATAI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 24 atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
    Apr 17 atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
    Apr 3 Atai Life Sciences upgraded at Maxim on Beckley investment
    Apr 1 Atai Life Sciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
    Mar 28 ATAI Life Sciences GAAP EPS of -$0.12 beats by $0.04
    Mar 28 atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
    Mar 27 atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression
    Mar 16 Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
    Mar 12 atai Life Sciences advances VLS-01 for treatment-resistant depression
    Mar 4 atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
    See more ATAI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.85
    52 Week Low 1.025
    Average Volume 1,762,572
    200-Day Moving Average 1.64
    50-Day Moving Average 1.98
    20-Day Moving Average 2.14
    10-Day Moving Average 1.98
    Average True Range 0.19
    RSI (14) 43.18
    ADX 21.26
    +DI 23.92
    -DI 22.37
    Chandelier Exit (Long, 3 ATRs) 2.28
    Chandelier Exit (Short, 3 ATRs) 2.24
    Upper Bollinger Bands 2.67
    Lower Bollinger Band 1.61
    Percent B (%b) 0.22
    BandWidth 49.53
    MACD Line -0.02
    MACD Signal Line 0.03
    MACD Histogram -0.0559
    Fundamentals Value
    Market Cap 305.46 Million
    Num Shares 166 Million
    EPS -0.43
    Price-to-Earnings (P/E) Ratio -4.28
    Price-to-Sales 859.87
    Price-to-Book 1.09
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.01
    Resistance 3 (R3) 2.01 1.97 1.98
    Resistance 2 (R2) 1.97 1.92 1.96 1.97
    Resistance 1 (R1) 1.90 1.90 1.88 1.90 1.96
    Pivot Point 1.86 1.86 1.85 1.85 1.86
    Support 1 (S1) 1.79 1.81 1.77 1.79 1.72
    Support 2 (S2) 1.75 1.79 1.74 1.71
    Support 3 (S3) 1.68 1.75 1.70
    Support 4 (S4) 1.68